GLP-1 telehealth ads on TikTok: what creators aren't disclosing

What did @jacklemay03 actually say?

The creator made a focused, specific allegation: TrimRx, a telehealth company in the GLP-1 weight loss space, used her video without permission. She did not make health claims. She made a conduct claim, and she made it clearly. Her words: "they steal content and it is completely outrageous." She also warned viewers that other creators appearing in TrimRx content are "almost 100%" not working with the company voluntarily. This is not a vague complaint, it is a named accusation against a named company.

She also added something that went beyond the legal complaint: she said TrimRx made her "look sickly," suggesting the edited or repurposed footage misrepresented her appearance or health status. That detail matters because it moves this from simple copyright infringement into something that could constitute false advertising or misleading health endorsement territory.

Does the science back this up?

There is no peer-reviewed science to cite here, and that is the point. This video is not making a clinical claim about GLP-1 medications. It is making a consumer protection and digital rights claim. But the broader context is worth naming.

The GLP-1 telehealth market has grown at a pace that has outrun regulatory oversight. A 2023 analysis published in JAMA Internal Medicine (Kanter et al., 2023) documented how direct-to-consumer telehealth platforms marketing compounded semaglutide frequently used aspirational imagery and implied endorsements that were not always clearly disclosed or consented to. The FTC has also flagged misleading endorsement practices in health and wellness advertising as an enforcement priority since 2022. Stolen or repurposed creator content fits squarely into that enforcement landscape. The creator is describing something regulators are actively watching for.

What did they get wrong (or right)?

She got the core allegation right, at least from a legal framework standpoint. Using someone's likeness or video content to imply a commercial endorsement without consent is a violation of both copyright law and FTC endorsement guidelines. If TrimRx used her footage to suggest she was a patient or advocate of their service, that compounds the problem: it is not just theft, it is potentially deceptive health advertising.

What she cannot verify publicly, and what viewers should not treat as confirmed, is her claim that "almost 100%" of creators appearing in TrimRx content did not consent. That may be true. It may not be. She is offering a reasonable inference based on her own experience, not confirmed testimony from every creator she is referencing. That caveat matters. It does not make her wrong about her own situation, but confident percentages applied to others should be held loosely.

She also said TrimRx made her "look sickly," implying appearance manipulation. That is a serious additional allegation that would require seeing the actual footage to evaluate. We cannot confirm it from this video alone.

What should you actually know?

If you are considering a GLP-1 telehealth platform, the conduct a company shows toward content creators is a signal worth paying attention to. Companies that cut corners on consent agreements tend to cut corners elsewhere. Regulatory shortcuts in marketing often correlate with regulatory shortcuts in clinical oversight.

FormBlends operates as a regulated telehealth platform. That means prescriber oversight, legitimate patient consent, and no borrowed credibility from creators who never agreed to represent us. It is worth asking any platform you consider: who are your prescribers, what is your compounding pharmacy's accreditation, and how do you handle advertising and endorsements?

The FDA has issued guidance specifically warning that compounded semaglutide is not the same as FDA-approved Wegovy or Ozempic (FDA, 2024). A platform's willingness to be transparent about what their product actually is, and who is actually endorsing it, tells you a lot about how they will treat your health data and clinical decisions.

Bottom line

This is a content theft and false endorsement allegation, not a health misinformation video. Take it seriously on its own terms. The creator named a company, described a specific harm, and warned other consumers. That is worth more than most GLP-1 content on TikTok, which is usually trying to sell you something.